COVID-19

blue coronavirus particles on dark background

Press Releases and Statements

CHPA Statement Regarding Study Regarding PPIs and COVID-19

The observational Internet survey results pre-published in the American Journal of Gastroenterology reporting an association between use of proton-pump inhibitor (PPI) medicines and self-reported positive tests for COVID-19 among people taking PPIs do not prove cause-and-effect.

Jan 10, 2020

OTC Medicines

Other Issues

COVID-19

white tablets being shaken from a bottle into a hand

Research Reports

Summary of State Sales Tax

State by state listing of whether OTC medicines are exempt from state sales tax or not.

Jun 1, 2018

OTC Medicines

Dietary Supplements

Consumer Medical Devices

Other Issues

COVID-19

Sales Tax Exemption

Pharmacist with long dark hair assisting customer in dark green shirt

Dispensing Authority

Given pharmacists' drug knowledge and public accessibility, states are exploring expanding their scope of practice permanently after the pandemic emergency measures expire. Empowering pharmacists to dispense products like oral contraceptives, and other consumer healthcare products could improve access and outcomes.

OTC Medicines

Other Issues

COVID-19

Same Sex Couple with Their Baby in the kitchen

FAQs

FAQs About HSA/FSA Accounts and the CARES Act

Supply Chain in the States

CHPA supports a review of existing rules and coordination efforts to identify opportunities that could mitigate shortage risks during times of peak need.

Federal Legislative Priorities

Learn about CHPA's current slate of federal legislative priorities including OTC regulatory reform, dietary supplement regulation modernization, supply chain and product integrity, and more.